Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,596Revenue (TTM) $M183Net Margin (%)-96.1Altman Z-Score5.7
Enterprise Value $M3,354EPS (TTM) $-1.5Operating Margin %-54.7Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-98.9Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %--Quick Ratio4.0Cash flow > EarningsY
Price/Sales18.75-y EBITDA Growth Rate %--Current Ratio4.3Lower Leverage y-yY
Price/Free Cash Flow111y-y EBITDA Growth Rate %--ROA % (ttm)-19.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-27.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M118ROIC % (ttm)-22.8Gross Margin Increase y-yN

Gurus Latest Trades with XON

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XONGeorge Soros 2016-03-31 Buy 0.05%$21.38 - $38.9
($31.64)
$ 30.43-4%New holding57,100
XONJoel Greenblatt 2016-03-31 Reduce-0.01%$21.38 - $38.9
($31.64)
$ 30.43-4%Reduce -59.45%23,282
XONJoel Greenblatt 2015-12-31 Buy 0.02%$29.56 - $42.8
($34.08)
$ 30.43-11%New holding57,418
XONFirst Eagle Investment 2015-12-31 Add0.01%$29.56 - $42.8
($34.08)
$ 30.43-11%Add 17.60%1,187,389
XONT Boone Pickens 2015-09-30 Sold Out -1.08%$29.39 - $68.71
($49.28)
$ 30.43-38%Sold Out0
XONFirst Eagle Investment 2015-09-30 Add0.01%$29.39 - $68.71
($49.28)
$ 30.43-38%Add 15.71%1,009,689
XONFirst Eagle Investment 2015-06-30 Add0.01%$37.33 - $50.71
($42.54)
$ 30.43-28%Add 5.37%872,604
XONT Boone Pickens 2015-03-31 Add0.9%$26.08 - $50.16
($37.59)
$ 30.43-19%Add 75.00%17,500
XONFirst Eagle Investment 2015-03-31 Add$26.08 - $50.16
($37.59)
$ 30.43-19%Add 4.84%828,104
XONT Boone Pickens 2014-12-31 Buy 0.53%$16.61 - $28.02
($23.05)
$ 30.4332%New holding10,000
XONDavid Einhorn 2014-12-31 Sold Out -0.05%$16.61 - $28.02
($22.97)
$ 30.4332%Sold Out0
XONDavid Einhorn 2014-09-30 Reduce-0.06%$17.86 - $26.59
($21.29)
$ 30.4343%Reduce -47.39%197,278
XONDavid Einhorn 2014-06-30 Reduce-0.39%$15.3 - $25.93
($21.15)
$ 30.4344%Reduce -72.81%375,000
XONFirst Eagle Investment 2014-06-30 Buy 0.04%$15.3 - $25.93
($21.15)
$ 30.4344%New holding661,564
XONDavid Einhorn 2014-03-31 Reduce-0.26%$22.5 - $36.82
($28.82)
$ 30.436%Reduce -37.58%1,379,014
XONT Boone Pickens 2013-12-31 Sold Out -0.47%$17.65 - $25.5
($21.05)
$ 30.4345%Sold Out0
XONDavid Einhorn 2013-09-30 Buy 0.86%$21.36 - $29.7
($24.16)
$ 30.4326%New holding2,176,868
XONT Boone Pickens 2013-09-30 Buy 0.47%$21.36 - $29.7
($24.16)
$ 30.4326%New holding12,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XON is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XON: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JCEO, 10% Owner 2016-05-13Buy41,830$23.9227.22view
KIRK RANDAL JCEO, 10% Owner 2015-12-11Buy124,475$29.851.94view
KIRK RANDAL JCEO, 10% Owner 2015-12-07Buy237,525$30.69-0.85view
Krishnan Krish SCOO 2015-12-04Sell20,900$35.66-14.67view
Krishnan SumaSVP--Product Development 2015-12-04Sell20,900$35.66-14.67view
KIRK RANDAL JCEO, 10% Owner 2015-01-27Buy555,556$2712.7view
KIRK RANDAL JCEO, 10% Owner 2014-05-13Buy65,173$15.19100.33view
Lehr Donald P.Chief Legal Officer 2014-05-13Buy1,850$15.9990.31view
Reed Thomas D.Chief Science Officer 2014-05-13Buy640$15.695.06view
Krishnan SumaSVP--Product Development 2014-05-09Buy20,900$14.21114.14view

Press Releases about XON :

Quarterly/Annual Reports about XON:

News about XON:

Articles On GuruFocus.com
CEO and Part Owner of JMP Group Invests in Company Jan 20 2016 
Intrexon Corp is expanding his business Jun 25 2015 
Bill Miller Identifies What Could Be The Stock of The Decade Feb 10 2015 
5-Year Lows: American Eagle Outfitters, Intrexon Corp, Mack-Cali Realty Corp, and Weight Watchers In Apr 20 2014 
Daniel Loeb Comments on Intrexon Corporation Jan 22 2014 
Daniel Loeb Lags S&P But Top New Stocks Advance Jan 07 2014 
David Einhorn’s New Stocks – TPX, XON, NVR Nov 14 2013 
Weekly CEO Buys Highlight: XON, ARCP, FSFR, CNTY, RHP Aug 18 2013 

More From Other Websites
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon... May 24 2016
Intrexon (XON) Stock Pops As Congress Hears Zika Testimony May 24 2016
The stocks fighting Zika May 24 2016
Final Trades: Salesforce, Allergan, & more May 23 2016
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Intrexon... May 23 2016
Intrexon to Present at Upcoming Investor and Industry Conferences May 23 2016
Intrexon to Present at Upcoming Investor and Industry Conferences May 23 2016
Oxitec CEO to Testify Before Congressional Committee on May 25th May 23 2016
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Intrexon... May 20 2016
INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds... May 20 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in... May 20 2016
Ziopharm Subpar Cancer Therapies Can't Support Lofty Market Valuation May 20 2016
INVESTOR NOTICE: Lundin Law PC Announces Investigation Of Intrexon Corporation And Advises Investors... May 19 2016
AquaBounty's AquAdvantage® Salmon approved by Health Canada May 19 2016
AquaBounty's AquAdvantage® Salmon approved by Health Canada May 19 2016
LEAD PLAINTIFF DEADLINE REMINDER: Hagens Berman Reminds Intrexon Corporation (NYSE: XON) Investors... May 19 2016
ETF’s with exposure to Intrexon Corp. : May 19, 2016 May 18 2016
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Investigation of Intrexon Corporation and... May 18 2016
ZIOPHARM Announces Clinical Data Highlighting Favorable Interim Survival Results with Gene Therapy... May 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)